5-bromo-4-chloro-3-indolyl beta-galactoside and Astrocytoma, Grade IV

5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breakefield, XO; Bureau, E; Kim, DE; Shah, K; Tang, Y; Weissleder, R; Yang, K	1
Castro, MG; Darling, JL; Lowenstein, PR; Maleniak, TC	1

Other Studies

2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Astrocytoma, Grade IV

Article	Year
Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Annals of neurology, 2005, Volume: 57, Issue:1 Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Brain Neoplasms; Cell Count; Cell Line, Tumor; Cell Movement; Cell Survival; Cell Transplantation; Cloning, Molecular; Diagnostic Imaging; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Galactosides; Glioblastoma; Green Fluorescent Proteins; Humans; Immunohistochemistry; Indoles; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mice, Nude; Mutagenesis; Neurons; Recombinant Proteins; Stem Cells; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2005
Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU. Cancer gene therapy, 2001, Volume: 8, Issue:8 Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured	2001

Article

Year

Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.

Annals of neurology, 2005, Volume: 57, Issue:1

Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Brain Neoplasms; Cell Count; Cell Line, Tumor; Cell Movement; Cell Survival; Cell Transplantation; Cloning, Molecular; Diagnostic Imaging; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Galactosides; Glioblastoma; Green Fluorescent Proteins; Humans; Immunohistochemistry; Indoles; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mice; Mice, Nude; Mutagenesis; Neurons; Recombinant Proteins; Stem Cells; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2005

Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell death in primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU.

Cancer gene therapy, 2001, Volume: 8, Issue:8

Topics: Adenoviridae; Antineoplastic Agents, Alkylating; Apoptosis; beta-Galactosidase; Brain Neoplasms; Combined Modality Therapy; DNA, Recombinant; Drug Resistance, Neoplasm; Fas Ligand Protein; Galactosides; Ganciclovir; Gene Expression; Genetic Therapy; Genetic Vectors; Glioblastoma; Herpesvirus 1, Human; Humans; Indoles; Lomustine; Membrane Glycoproteins; Thymidine Kinase; Tumor Cells, Cultured

2001